Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei Province, P.R. China.
J Pediatr Endocrinol Metab. 2022 Jun 3;35(7):901-912. doi: 10.1515/jpem-2022-0087. Print 2022 Jul 26.
The purpose of this study was to observe the relationship between metabolic syndrome (MetS) and height (Ht) adjusted Z-scores for areal bone mineral density (aBMD) in adolescents.
A retrospective study was conducted on the United States adolescents aged 12-17 years. Data were extracted from the National Health and Nutrition Examination Survey (NHANES) 2011-2012, 2013-2014 and 2015-2016 cycles. Ht adjusted Z-scores for aBMD were calculated.
A total of 969 adolescents (493 boys and 476 girls), aged 14.5 ± 1.7 years were enrolled in this study. After control for age, gender, race, 25-hydroxyvitamin D [25(OH)D], and lean body mass index (LBMI) Z-score, adolescents with MetS had significantly lower levels of total body (less head) aBMD Ht-Z-adjusted Z-score than adolescents with one, two components of MetS and without component of MetS (p<0.05) and significantly lower levels of lumbar spine aBMD Ht-Z-adjusted Z-score than adolescents with one component of MetS and without component of MetS (p<0.05). There were significantly negative associations between total body (less head) aBMD Ht-Z-adjusted Z-score and waist circumference (WC) (β=-0.027, p<0.001, R=0.057) and homeostasis model assessment insulin resistance (HOMA-IR) (β=-0.225, p<0.001, R=0.016). There were significantly negative associations between lumbar spine aBMD Ht-Z-adjusted Z-score and WC (β=-0.039, p<0.001, R=0.058) and HOMA-IR (β=-0.251, p<0.001, R=0.008).
The present study demonstrates that MetS may have a negative effect on bone mineral density in adolescents. Abdominal obesity and insulin resistance play a major role on the decline of aBMD in adolescents.
本研究旨在观察青少年代谢综合征(MetS)与骨矿物质密度(aBMD)身高调整 Z 评分之间的关系。
对美国 12-17 岁青少年进行回顾性研究。数据取自 2011-2012、2013-2014 和 2015-2016 年国家健康和营养调查(NHANES)。计算 aBMD 身高调整 Z 评分。
本研究共纳入 969 名青少年(493 名男孩和 476 名女孩),年龄为 14.5±1.7 岁。在控制年龄、性别、种族、25-羟维生素 D[25(OH)D]和瘦体重指数(LBMI)Z 评分后,与无代谢综合征组分、仅有一个组分和有两个组分的青少年相比,患有代谢综合征的青少年全身(非头部)aBMD 身高调整 Z 评分明显较低(p<0.05),且腰椎 aBMD 身高调整 Z 评分明显较低(p<0.05)。全身(非头部)aBMD 身高调整 Z 评分与腰围(WC)(β=-0.027,p<0.001,R=0.057)和稳态模型评估胰岛素抵抗(HOMA-IR)(β=-0.225,p<0.001,R=0.016)呈显著负相关。腰椎 aBMD 身高调整 Z 评分与 WC(β=-0.039,p<0.001,R=0.058)和 HOMA-IR(β=-0.251,p<0.001,R=0.008)呈显著负相关。
本研究表明,代谢综合征可能对青少年的骨矿物质密度产生负面影响。腹部肥胖和胰岛素抵抗在青少年 aBMD 下降中起主要作用。